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a  b  s  t  r  a  c  t
Stimulation  of  mitochondrial  oxidative  metabolism  by  Ca2+ is now  generally  recognised  as  important  for
the control  of cellular  ATP  homeostasis.  Here,  we review  the  mechanisms  through  which  Ca2+ regulates
mitochondrial  ATP  synthesis.  We  focus  on  cardiac  myocytes  and  pancreatic  -cells,  where  tight  control
of  this  process  is  likely  to  play  an  important  role  in  the  response  to  rapid  changes  in  workload  and  to
nutrient  stimulation,  respectively.  We  also  describe  a novel  approach  for imaging  the  Ca2+-dependent
regulation  of  ATP levels  dynamically  in  single  cells.








Mitochondria are the major site of oxidative metabolism, and
ence ATP synthesis, in eukaryotic cells. Thus, whereas the gly-
olytic metabolism of glucose generates 2 ATP molecules, 36–38
re generated by the reactions of the citrate cycle and the oxidation
f the resulting NADH and FADH2 by the respiratory chain [1].  The
atter reactions are tightly controlled by intramitochondrial Ca2+ in
 mechanism designed to ensure that ATP synthesis is closely cou-
led to the cell’s energetic needs. We  discuss this form of regulation
n detail here, taking as examples two cell types with contrasting
nergetic needs, the cardiac myocyte and the pancreatic  cell.
. Ca2+ regulation of intramitochondrial oxidative
etabolism: a brief historical perspective
Mitochondrial oxidative metabolism has long been recognised
s subject to complex regulation by several factors, notably the
Abbreviations: [ATP/ADP]c, cytosolic ATP/ADP ratio; [Ca2+]c, [Ca2+]m, cytosolic
nd  mitochondrial free concentrations of calcium; EC, excitation-contraction; ICEU,
ntracellular energy unit; KATP, ATP-sensitive K+ channel; MCU, mitochondrial uni-
orter; mNCX/NCLX, mitochondrial sodium-calcium exchanger; Pi, PPi, inorganic
hosphate and pyrophosphate, respectively; RuR, ruthenium red.
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Open access under CC BY license.concentrations of ADP and substrate(s) [2].  However, regulation
by Ca2+ has emerged in recent years as a further important means
of controlling this vital aspect of cell function. Mammalian mito-
chondria have a huge capacity for Ca2+ uptake and for many years
it was thought that these organelles served as mobilisable intra-
cellular reservoirs of Ca2+ ions [3].  Studies in the 1970s and 80s
by Denton and McCormack [4] as well as Hansford and Castro [5]
and Crompton [6] indicated instead that under basal conditions
total mitochondrial Ca2+ content was  low and that increases in
cytosolic free Ca2+ ([Ca2+]c) in response to extrinsic agents (nutri-
ents, hormones, neurotransmitters, etc.), were likely to provoke
increases in intramitochondrial free Ca2+ ([Ca2+]m) concentrations.
Thus, based on the properties of a group of key intramitochondrial
dehydrogenases (later characterised in some detail – see the fol-
lowing sections) [7,8], it was proposed that the uptake of Ca2+
ions from the cytosol increased [Ca2+]m from ∼0.1 to 10 M or
more. The consequent activation of oxidative metabolism would
then provide an increased supply of reducing equivalents to drive
respiratory chain activity and ATP synthesis. Export of mitochon-
drial ATP in exchange for ADP was  anticipated then to meet an
increased ATP demand to fuel energy-requiring processes in the
cytosol such as ion pumping, contraction, exocytosis etc. The bio-
chemical analyses (e.g. [9])  upon which the above model was based
were subsequently complemented and reinforced in the 1990s by
highly selective measurements of intramitochondrial free Ca2+ in
living cells by Rizzuto, Pozzan, Rutter and others [10,11].  These




























































lA.I. Tarasov et al. / Ce
hotoprotein aequorin, targeted to the mitochondrial matrix by in-
rame fusion with the signal peptide of cytochrome c subunit VIII.
ater extended by Rutter et al. to measurements at the level of single
ells [12], this approach provided evidence that basal intramito-
hondrial Ca2+ levels were indeed low (similar to or lower than
hose in the cytosol, i.e. ≤100 nM)  and that the free concentrations
f the ion increased within mitochondria in response to Ca2+-
obilising agonists. Subsequent reﬁnements of these approaches,
ncluding the use of GFP-based probes, highlighted the importance
f close contacts between the endoplasmic reticulum and mito-
hondria in the uptake of Ca2+ by the latter [13] and demonstrated
hat mitochondrial Ca2+ increases stably elevate mitochondrial
ATP] [14].
. Mitochondrial Ca2+ transport: roles of the mitochondrial
niporter MCU  and the Na+/Ca2+ exchanger, mNCX/NCLX
An impediment to progress in this ﬁeld has been that the mito-
hondrial Ca2+ transport proteins were not puriﬁed or cloned, and
hat use of the inhibitors of these pathways is problematic in living
ells. However, recent work has very likely identiﬁed the proteins
esponsible for both the Ca2+ inﬂux and Ca2+ efﬂux pathways in
itochondria (see below).
Increases in [Ca2+]c are relayed to the mitochondria by the
itochondrial Ca2+ uniporter (MCU), resulting in activation of
itochondrial dehydrogenases and stimulation of ATP synthe-
is. Average [Ca2+]m is controlled by the activities of the MCU
nd the efﬂux pathway, the mitochondrial Na+/Ca2+ exchanger
mNCX). Ca2+ uptake is respiration-dependent, thus high rates of
ptake can effectively lower the mitochondrial membrane poten-
ial (m) (reviewed in [15]). This phenomenon can be observed
learly in isolated mitochondria at supraphysiological concentra-
ions of extramitochondrial Ca2+; however, under physiological
onditions of Ca2+ uptake, a change in m has not been detected
n isolated cardiomyocytes using ﬂuorescent indicators. Thus, Ca2+
ptake would not normally be expected to lower the membrane
otential, at least for a sustained period, or to such an extent that
t would inhibit ATP synthesis. Nonetheless, transient and small
ecreases in mitochondrial membrane potential may  occur during
ytosolic Ca2+ peaks in other systems, and can be observed in pan-
reatic  cells by following rhodamine-123 accumulation [16] or
ensitive ﬂuorescent ATP probes (Tarasov and Rutter, unpublished
nd see below).
The Ca2+ transport pathways of mitochondria are covered in
ore detail by other reviews in this issue. However, a brief
iscussion of their properties speciﬁcally with regard to energy
roduction will be given here.
Early studies on isolated mitochondria characterised the MCU
s a low afﬁnity, high capacity transporter of Ca2+, whereas the
NCX had a much lower Vmax, saturating at [Ca2+]m below 1 M
reviewed in [17,15]). Thus, it was predicted that net Ca2+ inﬂux
ould occur only when external [Ca2+] rose above about 500 nM,
uch higher than normal resting [Ca2+]c of 100–200 nM [18].
tudies in living adult rat myocytes [Ca2+]m conﬁrmed this pre-
iction, since [Ca2+]m remained less than [Ca2+]c until the latter
ose above 500 nM [18]. However, the seminal paper by Rizzuto,
ozzan and colleagues in 1992, using aequorin targeted to mito-
hondria, revealed that these organelles were capable of taking
p Ca2+ on a fast timescale, due to their proximity to intracellular
a2+ stores [10] so they would effectively “see” much higher [Ca2+]c
han that of the bulk cytosol. In some cells and species [Ca2+]m has
een reported to change in response to physiological, submicro-
olar, changes in [Ca2+]c; but, in cardiomyocytes for example, the
eﬂected changes in [Ca2+]m were small, 10–20 nM [19].
Research into the mitochondrial Ca2+ transporters is now
ikely to undergo another step change, with the identiﬁcation ofium 52 (2012) 28– 35 29
proteins corresponding to both MCU  and mNCX. Two papers pub-
lished simultaneously in 2011 identiﬁed a Ca2+ uptake pathway
in mitochondria, inhibited by ruthenium red: Baughman et al.
[20] identiﬁed the MCU  as a novel predicted transmembrane pro-
tein (CCD109A) that formed oligomers in the inner membrane,
and interacted with their previously identiﬁed regulator protein,
MICU1. Silencing MCU  in cultured cells or in vivo in mouse liver
abrogated Ca2+ uptake, but membrane potential and respiration
remain intact. A point mutation removed the sensitivity to ruthe-
nium red (RuR). The other paper [21] identiﬁed MCU  as a 40 kD
protein with 2 transmembrane regions. RNA silencing of MCU  in
HeLa cells reduced mitochondrial Ca2+ uptake, and puriﬁed MCU
reconstituted in bilayers exhibited Ca2+ channel activity that was
sensitive to RuR.
In 2010, Palty et al. [22] identiﬁed NCLX in mitochondria – this
protein is a novel NCX, lying in an ancestral branch of the NCX
superfamily. The protein occurred as 50, 70 and 100 kD forms in
mitochondrial fractions of mouse heart and brain; the 100 kD form
likely representing dimers. The authors demonstrated that mito-
chondrial Ca2+ efﬂux was  enhanced upon over-expression of NCLX
in HEK 293 cells and inhibited by CGP 371457, and that Ca2+ efﬂux
was  greatly reduced using an anti-NCLX siRNA.
4. Ca2+ sensitive mitochondrial enzymes
4.1. FAD-glycerol phosphate dehydrogenase (FAD-GPDH)
Physiological levels of [Ca2+]c regulate FAD-GPDH (K0.5  0.1 M
in rat liver mitochondrial extracts [23]), via a cytosol-facing EF-
hand binding site for Ca2+ [24]. Increases in extramitochondrial
Ca2+ lowered the KM for DL-glycerolphosphate (K0.5 = 30–100 nM)
in permeabilized INS1  cells [25].
4.2. Pyruvate dehydrogenase phosphatase (PDHP)
The 50 MDa  pyruvate dehydrogenase (PDH) multi-
enzyme complex catalyses the irreversible reaction:
pyruvate + CoA + NAD → acetyl-CoA + NADH2 + CO2, with the
product, acetyl-CoA, then entering the citrate cycle or fatty
acid synthesis. The complex comprises multiple copies of three
enzymes: E1 (that decarboxylates pyruvate); E2 (forms acetyl-CoA)
and E3 (reduces NAD+ to NADH).
The activity of the PDH complex is a rate-limiting step for glu-
cose oxidation and is therefore reﬂected in the rate of respiration
and ATP synthesis in mammalian tissues [26]. The regulation of
the PDH complex activity is achieved via end-product inhibition
and reversible phosphorylation by a PDH kinase, which inhibits
the activity of E1 subunit via phosphorylation at three sites around
S293 [27,28].  A Mg2+-dependent PDH phosphatase, in turn, dephos-
phorylates the E1 subunit.
The activity of the Ca2+-regulated phosphatase depends on the
association of the catalytic subunit of the predominating isoform 1
of PHD phosphatase (PDHP1c) and the L2 domain of the E2 subunit
of the PDH complex, which is potentiated by Ca2+ [29]. PDHP1c
and the L2 domain of the E2 subunit lack Ca2+ binding motifs so
the binding site for the cation is likely to be formed jointly by
residues of both interacting proteins [30]. Ca2+ activates the phos-
phatase in heart mitochondrial extracts with K0.5 of ∼1 M [31]
and extramitochondrial Ca2+ stimulates phosphatase activity over
the physiological range (0.1–1.0 M),  in rat heart [32] liver [33] and
adipose tissue [34] mitochondria.4.3. NAD+-isocitrate dehydrogenase (NAD-ICDH)
NAD-ICDH is a hetero-octamer consisting (in eukaryotes) of
2 × (2˛,ˇ,) subunits [35]. The enzyme binds ∼2Ca2+/octamer [7]
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ut the binding site is as yet unknown. In the presence of ADP, Ca2+
ecreased the KM for isocitrate ∼8-fold [36]) with a K0.5 for Ca2+
f 1.2 M in mitochondrial extracts [37] and 5–43 M (increas-
ng with ATP/ADP ratio), in toluene-permeabilised mitochondria
38]. ADP (or ATP) and Mg2+-isocitrate are required for Ca2+ bind-
ng [7].  The lower sensitivity of this enzyme to Ca2+ compared to
ther intramitochondrial dehydrogenases may  extend the range
ver which Ca2+ is able to modulate oxidative metabolism by these
rganelles [8].
.4. 2-Oxoglutarate dehydrogenase (OGDH)
The OGDH complex, similarly to the PDH complex, consists of
ultiple copies of three subunits: E1 (-ketoacid decarboxylase),
2 (dihydrolipoyl transacetylase) and E3 (dihydrolipoamide dehy-
rogenase) [39]. The activity of the complex is directly regulated
y Ca2+, most likely via the E1 subunit [40] (K0.5 = 1–7 M in mito-
hondrial extracts) [7].  Each enzyme complex binds ∼3.5Ca2+ ions,
uggestive of a Ca2+ binding site at E1 dimer interfaces [7].  Ca2+
ecreases the KM for 2-oxoglutarate with little effect on Vmax [41].
he K0.5 for extramitochondrial Ca2+ is ∼0.15 M in intact heart
itochondria [37,42].
.5. F1–FO ATP synthase
The possibility that the rate of ATP production can be regu-
ated independently from the respiration rate or mitochondrial
embrane potential (m) has been demonstrated in intact mito-
hondria [43] and conﬁrmed using control theory analysis [44].
arly in vitro [45] and in vivo [46] studies reported F1–FO syn-
hase as a potential target of this regulation. Although shown to
ind Ca2+ directly [47], the F1–FO ATP synthase is likely to be reg-
lated via post-translational modiﬁcations and phosphorylation of
he -subunit was sensitive to mitochondrial Ca2+ [48] with a K0.5
n the M range. Recent work has identiﬁed a protein that binds
o the F1–FO synthase in Ca2+-dependent manner, resulting in an
ncreased capacity for ATP production [49].
.6. Other potential mitochondrial targets for Ca2+
Cytochrome c oxidase (COX) is allosterically inhibited by ATP/ADP
binding to the matrix domain of subunit IV). This inhibition is
witched on by the cAMP-dependent phosphorylation of subunits
I (and/or) III and Vb by protein kinase A (PKA), and results in an
nhanced H+/e-stoichiometry and therefore more efﬁcient energy
ransduction. Ca2+-dependent phosphatase reverses the cAMP-
ediated effect (in vitro or in isolated mitochondria) [50]. cAMP
s likely to stimulate the phosphorylation at Tyr304 of subunit I,
hich decreases the Vmax and increases the KM. COX binds Ca2+
ith a Kd of around 1 M,  competitively with Na+ [51].
Malate–aspartate shuttle activity. Ca2+ activates this shuttle in
rain mitochondria (K0.5 = 0.3 M)  [52]. The aspartate–glutamate
ransporter has a cytosolic EF domain and is also regulated by
Ca2+]c, albeit in the supraphysiological range [53].
Pyrophosphatase activity in liver and heart mitochondria is
nhibited by Ca2+, due to competition of CaPPi with MgPPi
K0.5 = 12 M)  [54]. The accumulation of PPi is expected to result
n an increase in mitochondrial volume and activation of the respi-
atory chain.
The ATP-Mg2+/Pi transporter (SCaMC1).  This transporter is stim-
lated by extramitochondrial Ca2+ and may  regulated the total
ontent of adenine nucleotides inside mitochondria, and hence
lter Ca2+ buffering. SCaMC1 is overexpressed in some cancer cell
ines, and this has been proposed to contribute to the ability of the
ells to withstand Ca2+ loads that would otherwise trigger opening
f the mitochondrial permeability transition pore [56].Fig. 1. Role of Ca2+ uptake by mitochondria in the heart.
Ca2+ reportedly potentiates fatty acid oxidation to -
hydroxybutyrate [55] though the underlying mechanisms are not
understood.
5. Role of mitochondrial Ca2+ transport in speciﬁc cell types
5.1. Cardiac myocyte
Fig. 1 presents a summary of the model proposed for mitochon-
drial Ca2+ uptake in the control of ATP synthesis in the heart.
Oxidative phosphorylation in mitochondria provides over 90%
of ATP production in the heart [45]. The overall equation is given
below, although estimates of the number of ATP molecules synthe-
sised per molecule of NADH vary:
NADH + H+ + O2 + 2.5ADP + 2.5Pi → NAD+ + H2O + 2.5ATP
ATP production can potentially be regulated by several differ-
ent mechanisms, such as increases in NADH/NAD+ and ADP/ATP.
It was originally proposed that changes in the ADP/ATP ratio were
the main regulator of ATP synthesis [2],  and this was  easily demon-
strated in isolated mitochondria. However, later experiments using
isolated beating rat hearts found that high energy phosphate levels
did not change under conditions that imposed a large increase in
energy demand, e.g. increases in workload of the heart [57,58].  In
fact utilisation of ATP under these conditions was exactly matched
by an increase in ATP production. Changes in ATP are initially
buffered by the phosphocreatine system but this only lasts for a
few seconds, implying the existence of alternative mechanisms for
rapidly increasing ATP synthesis.
This role was  later found to be fulﬁlled by intramitochon-
drial Ca2+, following the discovery of the activation by Ca2+ of
mitochondrial enzymes, as discussed above, namely the matrix
dehydrogenases PDH [31], NAD-ICDH [37], OGDH [9],  and possibly
the ATP synthase [59]. The observations led Denton, McCormack
and colleagues to propose that an increase in the supply of reduc-
ing equivalents in the form of NADH and FADH2 resulting from
Ca2+ activation of the dehydrogenases would increase ATP produc-
tion; thus suggesting a parallel activation model of stimulation of
contraction and ATP synthesis by Ca2+ [60,61] (and see Fig. 1). The
mitochondrial F1F0ATP synthase (ATPase) may  also be stimulated
by Ca2+ in this setting [43,47,62,63].
Whether Ca2+ transport into mitochondria occurs in the heart,
and whether or not [Ca2+]m changes on a beat-to-beat basis in this
organ, has remained controversial for some time. Based on work
in isolated mitochondria, the MCU  and mNCX pathways could cer-
tainly not respond quickly enough to the very rapid (ms) changes
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owever, more recent work using isolated myocytes has suggested
hat mitochondrial Ca2+ transients do occur during EC coupling
n neonatal and adult cardiac myocytes [64–66].  There is conﬂict-
ng data on this in the literature since other studies reported that
itochondrial Ca2+ accumulation occurred over tens of seconds
n cardiac myocytes [18,67,68].  Part of the conﬂict may  be due to
ifferent species or stage of development (neonate versus adult),
lthough why and how mitochondrial Ca2+ spiking occurs in some
pecies but not others remains unknown. However, there is agree-
ent that the main role of MCU  and mNCX under physiological
onditions is to translate or decode cytosolic Ca2+ signals in the
itochondria, so that Ca2+ activation of mitochondrial metabolism
ccurs.
In addition to the known proximity of mitochondria to the ER
n a variety of cell types, there is now evidence for a direct physical
oupling that persists during isolation of mitochondria (reviewed in
69]). This evidence was provided in heart by isolation of mitochon-
rial fractions with associated SR components that were highly
esistant to puriﬁcation [70]. These “SR appendices” were capa-
le of transferring Ca2+ directly to mitochondria (measured with
hod-2 ﬂuorescence) upon stimulation with caffeine (which acti-
ated the ryanodine receptor, thus triggering release of Ca2+ from
he SR), and of increasing the NADH autoﬂuorescence signal, sug-
esting activation of the dehydrogenases. This was the ﬁrst direct
vidence that Ca2+ transfer directly from the SR to mitochondria is
apable of activating oxidative metabolism [70].
Activation of ATP synthesis in the heart by mitochondrial Ca2+.
arallel measurements of [Ca2+]m and [Ca2+]c in rat myocytes
evealed that resting [Ca2+]m was about 80 nM compared with rest-
ng [Ca2+]c of 150 nM [18]. Whereas in mitochondria isolated from
eating hearts the [Ca2+]m was estimated to be slightly higher,
bout 170 nM [71]. Upon rapid stimulation in presence of an adren-
rgic agonist (myocytes), or increased workload (isolated hearts),
he value of [Ca2+]m increased to 500–1000 nM [18,71]. These val-
es of [Ca2+]m under physiological conditions are within the range
or activation of the dehydrogenases (see above).
There is also evidence to suggest that extramitochondrial
a2+ regulates substrate supply into mitochondria via the
spartate–glutamate carrier (aralar) and the malate–aspartate
huttle (see above). This newer mechanism has been proposed to
ct as a “gas pedal, supplying.  . .substrate on demand” [72].
A problem in elucidating the relationship between [Ca2+]m and
ATP] was that although ATP has been measured in whole hearts,
nd now in animals and humans using non-invasive 31P-NMR
reviewed in [73]), only relatively slow responses were measured,
nd so it could not be determined whether ATP was varying beat-
o-beat, or during the time taken for mitochondria to accumulate
ufﬁcient Ca2+ to activate the dehydrogenases.
We  directly measured ATP in mitochondria and cytosol, [ATP]m
nd [ATP]c, respectively, using targeted luciferase [64], and [Ca2+]m
nd [Ca2+]c using targeted aequorin: in adult cardiac myocytes
timulated to contract at 2 Hz, there was no change in [ATP] in either
ompartment on addition of isoproterenol, despite an increase in
ontractile force and increases in both [Ca2+]m and [Ca2+]c. This
ndicated that [ATP]c was extremely well-buffered in myocytes,
.e. that the rate of ATP supply and/or synthesis can keep pace
ith that of ATP breakdown, even under conditions that imposed
 large energy demand on the cell. This lack of change in [ATP] is in
greement of studies using whole hearts [74].
However, when we allowed cells to rest, then suddenly stimu-
ated to contract in the presence of isoproterenol (“standing-start”
xperiments), [ATP]m showed a signiﬁcant transient drop (up to
2% in some cells) followed by recovery to higher than initial
evels [64]. These changes likely reﬂect an initial activation of
TP-requiring processes in the cytosol, such as ion pumps and
ontractile proteins, which would cause a drop in [ATP]m before aium 52 (2012) 28– 35 31
time-dependent activation of mitochondrial oxidative metabolism
by Ca2+ stimulated ATP synthesis [75]. The changes in [ATP]c were
much smaller than those in the mitochondrial matrix, again sug-
gesting that even when [ATP]m does change, the cytosolic energy
supply is very rapidly matched to the increased demand. The lag
phase where [ATP]m falls before recovering, exactly matches the
time course for [Ca2+]m to increase [64,76].
Similarly it has been generally observed that under conditions
of adequate oxygen consumption, NAD(P)H levels remain constant
in beating hearts and myocytes, again highlighting that ATP supply
and demand are extremely well-coupled. The only time NAD(P)H
was  observed to decrease was in similar experiments to the “stand-
ing start” experiments described above, where there was an initial
drop in NAD(P)H levels before recovery, again being slightly pre-
ceded by an increase in [Ca2+]m [77].
Do ADP and Ca2+ have joint role in regulating ATP production
in myocytes? Balaban [73] has argued that, given the impor-
tance of ensuring a rapid response system of ATP synthesis in
the myocardium, more than one mechanism is likely to operate
to coordinate ATP supply and demand. Whether [Ca2+]m is abso-
lutely required to maintain ATP levels during continuous or large
increases in energy demand is not yet known and the idea of [Ca2+]m
being the only factor that is important physiologically in regulat-
ing ATP supply and demand is not universally accepted. Our own
studies show that in rat cardiac myocytes when stimulation rate
is increased from 0.2 Hz to 4 Hz, which presumably causes a large
increase in ATP demand, there is very little change in [Ca2+]m unless
an adrenergic agonist is also present [67]; presumably this may
increase the systolic [Ca2+]c sufﬁciently that MCU  is activated to
increase [Ca2+]m.
One possibility is again that of the subcellular arrangement of
mitochondria and proximity to other cell compartments: Saks and
colleagues have put forward the idea that the subcellular architec-
ture changes during contraction, causing a decrease in the apparent
KM of ADP for stimulating respiration, and removing diffusion lim-
its of ADP that occur in resting cells (reviewed in [78]). This requires
the mitochondria to be organised in structural units with ATP
consuming processes in the cell, such as myoﬁbrils, SR and sar-
colemmal ATPases, so-called “intracellular energy units (ICEUs)” –
where channelling of ADP occurs.
This group also argues that [Ca2+]m may  not be the sole fac-
tor, or possibly not a major factor, in regulating ATP supply and
demand in the heart, since modelling studies have predicted that
the increase in [Ca2+]m in the heart would only be enough to stimu-
late respiration 2–3 fold, whereas increases of 10–20-fold are seen
in vivo [43,79]. Therefore localised regulation of [ADP] in the ICEUs
would present a method of stimulating ATP synthesis by mitochon-
dria without changes in bulk [ADP] or [ATP] [80]. However, it is not
clear how far these studies can be extrapolated to the physiolog-
ical situation of rapidly beating cardiac myocytes, either cells or
whole hearts that are continually shortening and re-lengthening.
If the authors are correct, the theory also implies that control of
respiration by ADP is operating on a millisecond timescale (in rat
cardiac myocytes, for example). Alternatively, respiration could be
sensitive to the time-averaged local [ADP], in a similar manner as
we suggested above for rapid changes in [Ca2+]m.
Implications for cardiac disease. Pathologically, an increase in
[Ca2+]m has been associated with the transition from reversible to
irreversible cell injury in ischaemia/reperfusion injury of the heart,
and a major contributing factor to this injury is Ca2+-induced open-
ing of the mitochondrial permeability transition pore [81,82].  A role
for [Ca2+]m in heart failure, and for the mitochondrial Ca2+ efﬂux
pathway in the treatment of this condition has also been suggested
[83].
Both MCU  and mNCX have been proposed as possible targets
for cardioprotective drugs (reviewed in [76]). However, protective






























































levels rise – thus contributing to the well-known highly sigmoidal
response of insulin secretion to blood glucose levels [95]. This pos-
itive feedback may  play an important role in coordinating insulin2 A.I. Tarasov et al. / Cel
ffects of RuR have been found in ischaemia reperfusion injury
[84,85]), although it is not certain that the drug was  acting on
CU  since it is not speciﬁc and also affects SR Ca2+ ﬂux [86]. Indeed
e found, using a myocyte model of hypoxia/reoxygenation injury,
hat RuR was not protective [87], but that inhibiting the mNCX with
lonazepam was. We  concluded that the route of Ca2+ entry into
itochondria under hypoxic conditions is likely to be the mNCX
ather than MCU  [87,88].
The mNCX has also been considered a target for cardioprotec-
ion in heart failure. Recent work from O’Rourke’s group has shown
hat dysregulation of Na+ homeostasis in heart failure may  be a pri-
ary cause of mitochondrial dysfunction: in a guinea-pig model
f heart failure (induced by aortic constriction), intracellular [Na+]
as 16 mM compared with 5 mM in control cells [89]. Rapid pacing
f the cells induced a decrease in NADH ﬂuorescence, an indirect
ndicator of respiratory chain activity, whereas this was  maintained
n controls. CGP 37157, an inhibitor of mNCX, was able to prevent
he decrease in NADH in the failing myocytes. It is thus likely to
estore ATP levels although this has yet to be shown directly: ear-
ier work showed that the mNCX is capable of regulating [Ca2+]m
nd dehydrogenase activity since adding Na+ to isolated mitochon-
ria shifts the activation curves for PDH and OGDH by Ca2+ to the
ight [32].
.2. The pancreatic islet ˇ-cell
Insulin secretion from pancreatic -cells is prompted by
ncreases in blood glucose over the physiological range (4–8 mM),
hanks to the expression of high KM glucose transporters (Glut2
n rodents) and glucokinase [90]. Defective -cell glucose sensitiv-
ty [91,92] as well as a decrease in numbers of these fuel-sensing
ells [93,94] result in hyperglycaemia and eventually type 2 dia-
etes.
The metabolic conﬁguration of -cells is adapted to favour
he complete oxidation of glucose by mitochondria [95] through
he suppression of genes involved in the production of lactate
LDHA and the plasma membrane monocarboxylate transporter,
LC16A1/MCT1) [96–99],  and the expression at high levels of
AD-GPDH [24,25,100]. Consequently, increases in extracellular
lucose are obligatorily linked to increased ﬂux through the citrate
ycle [100] and lead to clear elevations in cytosolic ATP/ADP ratio
101], which block ATP-sensitive K+ (KATP) channels on the plasma
embrane [102]. This triggers plasma membrane depolarisation,
lectrical activity and Ca2+ inﬂux into the cytosol via voltage-gated
a2+ channels [103]. The elevated [Ca2+]c then triggers exocyto-
is of insulin granules [90,104] (Fig. 2). Other, more poorly deﬁned
KATP-independent” effects of glucose, possibly involving the inhi-
ition of AMP-activated protein kinase [105,106],  also contribute
o “amplifying” effects of the sugar on secretion [107]. Changes in
TP/ADP ratio also regulate exocytosis directly [108], modulating
he effects of cAMP [109,110].
In  contrast to most tissues including the heart (see above),
ytosolic ATP changes over a relatively wide range in -cells [111]
nd this is likely to play a key-signalling role. Our early mea-
urements of glucose-induced ATP dynamics in MIN6 and primary
slet  cells [75,112,113], using the recombinant bioluminescent
eporter ﬁrely luciferase (an approach whose sensitivity is rel-
tively poor), suggested a monophasic elevation of ATP occurs
n response to high glucose, although evidence for oscillations
as also obtained [113,114].  Signiﬁcant differences between the
lucose-induced changes in the bulk cytosol and a sub-plasma
embrane “microdomain”, as well as the mitochondrial matrix,
ere also demonstrated [75]. Importantly, blockade of Ca2+ inﬂux
ith EGTA or through the inhibition of voltage-gated Ca2+ channels
ubstantially inhibited glucose-induced ATP/ADP increases, impli-
ating a role for Ca2+ inﬂux in metabolic control [113].Fig. 2. Potential role of Ca uptake by mitochondria in the pancreatic -cell. ETC,
electron transport chain. See the text for further details of the Ca2+ sensitive intrami-
tochondrial dehydrogenases.
In light of the above limitations, we have recently estab-
lished a technique whereby [Ca2+]m can be imaged in real time
in single primary living -cells using a mitochondrially tar-
geted, adenovirally-delivered and GFP-based reporter (“Pericam”;
2mt8RP) simultaneously with [Ca2+]c measured with the trappable
small molecule, Fura Red (Fig. 3). Importantly, after the formation
of a perforated patch, imaging of the two probes can be performed
simultaneously with recordings or manipulation (at will) of plasma
membrane potential. This approach demonstrates that [Ca2+]m is
unable to track fast oscillations of [Ca2+]c, imposed by single action
potentials that have the duration of 50–200 ms in -cells [115].
However, [Ca2+]m does follow slow changes in [Ca2+]c similar to
those associated with slow electrical bursting [115]. This “accumu-
lation” mechanism makes [Ca2+]m highly sensitive to the frequency
of Ca2+ oscillations [115] (Fig. 4), such that low frequency spiking
barely affects [Ca2+]m. This “Frequency-Amplitude” demodulation
may  thus allow ﬁltering of low level stimulation (for example at low
glucose concentrations) whilst amplifying the response as glucoseFig. 3. Principle of simultaneous patch-clamp recording and multiparameter imag-
ing  of compartmentalised Ca2+ and ATP/ADP in single cells.
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Fig. 4. Mitochondrial Ca2+ (A) and [ATP/ADP]cyt (B) increases respond to the frequen





























sig. 5. Multiphasic increases in [ATP/ADP]c are prompted by high glucose in the
-cell. Recordings and image collection were as in Fig. 4; note the second phase of
TP/ADP increase ∼400 s after the increase in glucose [115].
ecretion in pancreatic islets where -cells are electrically cou-
led [116]. Using the same approach to combine imaging of [Ca2+]c
nd [ATP/ADP]c, using the genetically encoded ﬂuorescent sen-
or Perceval [117], we have been able to demonstrate a biphasic
ncrease in [ATP/ADP]c in response to high glucose, with Ca2+ entry
nto cytosol being the key factor for the second phase [115] (Fig. 5).
These observations are consistent with a model for the -cell in
hich elevation of [Ca2+]c leads ﬁrstly to the activation of a number
f processes (e.g. Ca2+ pumping [118,119])  that elevate ATP con-
umption [101,113,115].  This is then matched by a Ca2+-dependent
otentiation of mitochondrial metabolism [115,120].  The exis-
ence of these two phases thus generates a biphasic increase in
ATP/ADP]c. (Fig. 5). Whilst the role in stimulus-secretion coupling
f the second phase is unclear, an intriguing possibility is that it is
nvolved in the mobilisation of secretory granules from a “reserve
ool” in the cell [95].
Consistent with these ﬁndings, silencing of MCU  [115], or
eployment of an intramitochondrial Ca2+ buffer [120], blocks
oth mitochondrial Ca2+ uptake and the second phase of ATP/ADP
ncrease. Interestingly, glucolipotoxic conditions mimicking the
iabetic milieu and known to affect mitochondrial integrity [121],
uppress [Ca2+]m changes and selectively reduce the second phase
f [ATP/ADP]c increase [115]. Defective mitochondrial Ca2+ han-
ling may  thus play a part in the defects in insulin secretion in type
 diabetes.
. ConclusionsThere is no doubt that [Ca2+]m plays an important role in
oth myocardial energy production and in intracellular Ca2+
ignalling in many other systems including the pancreatic -cell.cy of electrical bursting and Ca2+ oscillations in a single primary mouse -cell.
n−1 to 1 min−1 [115].
Future challenges will involve further dissection of the molecular
mechanisms involved (including identiﬁcation of the Ca2+ binding
sites on the mitochondrial dehydrogenases) and exploration of
the potential therapeutic use of new information ﬂowing from the
identiﬁcation of the molecular players in Ca2+ transport.
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